Catalyst Wire Dossier Catalyst Wire Dossier

Investigational cognition-enhancing drug candidate

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational cognition-enhancing drug candidate, covering 2015-07-30 to 2015-07-30. Get the full timeline:

Most recent: Clinical Trial Update: BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006) [Phase 1]

See pricing